REGENXBIO (NASDAQ:RGNX) Upgraded at Royal Bank of Canada
Royal Bank of Canada upgraded shares of REGENXBIO (NASDAQ:RGNX – Free Report) from a sector perform rating to an outperform rating in a research note released on Friday morning, Marketbeat Ratings reports. Royal Bank of Canada currently has $35.00 price objective on the biotechnology company’s stock, up from their prior price objective of $20.00. Several […]
More Stories
Earnings Season Is About to Begin, and I Expect Positive Changes
By Louis Navellier We’re approaching another earnings season, starting in mid-April, when many of our stocks shine the brightest. Some...
These Detransitioners Sued for Medical Malpractice, but Will They Get Their Day in Court
By Darlene McCormick Sanchez Prisha Mosley thought that she would get her day in court when the North Carolina Legislature...
Cyber Crimes Costing Americans Nearly $21 Billion: FBI
By Naveen Athrappully The FBI released its 2025 Internet Crime Report, revealing that Americans were being defrauded to the tune...
Iran’s Revolutionary Guard Warns Oil Will Be Cut Off ‘For Years’
By Jack Phillips Iran’s Islamic Revolutionary Guard Corps warned on April 7 that the paramilitary group would attempt to block...
California Leads Nation in Diesel Price Spike
By Bill Pan Diesel prices are rising across the nation, and California is taking an especially hard hit, as recent...
Trump Endorses Steve Hilton in Heated Race for California Governor
By Jill McLaughlin Republican Steve Hilton captured President Donald Trump’s endorsement on April 5 in his quest to become the...